Quest Diagnostics (DGX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 20, 2026, with voting available online or in person.

• Shareholders are encouraged to review proxy materials and vote on key proposals by May 19, 2026.

Voting matters and shareholder proposals

• Election of eleven directors, each recommended by the board.

• Advisory vote on executive officer compensation for 2026, with board recommending approval.

• Ratification of the appointment of the independent registered public accounting firm for 2026, recommended by the board.

• Stockholder proposal regarding an independent board chairman, with board recommending a vote against.

Board of directors and corporate governance

• Eleven nominees for the board, including a mix of experienced executives and industry professionals.

• Board recommends all nominees for election.